2014 Agenda

Below is a detailed agenda for the 4th Annual CCON Conference.
For your convenience, you may also print this agenda.


Thursday, May 8, 2014
7:30 – 22:00
TimeTopicLocation / Speaker
7:30 - 8:15Breakfast1st Floor Atrium with OHRC
8:15 - 8:20IntroductionCo-Chairs: Dr. Susan Dent & Dr. Christine Brezden-Masley
8:20 - 8:30Welcome AddressDr. Phil Wells

Senior Scientist, Clinical Epidemiology, Ottawa Hospital Research Institute; Professor, Chief & Chair, Department of Medicine, The Ottawa Hospital & University of Ottawa,
Ottawa, ON
8:30 - 9:15Ageing is a risk factor in imatinib mesylate cardiotoxicity

Discussion: 15 minutes
Dr. Wael Maharsy

Post-Doctoral Biochemistry Fellow, University of Ottawa, Ottawa, ON
9:15 - 10:00Cardio-Oncology: A New Platform for Basic and Translational Investigation

Discussion: 15 minutes
Dr. Javid Moslehi

Instructor, Department of Medicine, Harvard Medical School; Cardiologist, Brigham and Women’s Hospital,
Boston, MA
10:00 - 10:15Break1st Floor Atrium with OHRC
10:15 - 11:10CO-HOSTED PLENARY SESSION: Kinase inhibitors in cancer and the heart: Dealing with the other side of the coin

Discussion: 15 minutes
Dr. Thomas Force

Professor of Medicine, Clinical Director, Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA

Room 201 with OHRC
11:10 - 12:00DEBATE: Should preventative cardiac therapy (e.g. ACE inhibitors, beta blockers) be given to cancer patients with normal heart function before receiving potential cardiotoxic cancer therapy?Moderator: Dr. Michael Ewer

Debaters: Dr. Jean-Bernard Durand & Dr. Sean Virani
12:00 - 13:00Lunch1st Floor Atrium with OHRC
13:00 - 13:45Introduction to the NCI National Community Oncology Research Program: What does NCORP mean to CardioOncology?

Discussion: 15 minutes
Dr. Michael Fisch

Chair, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center Houston, TX
13:45 - 14:30Echocardiography in the detection of cardiotoxicity

Discussion: 15 minutes
Dr. Rajeev Rao

Echocardiography Fellow, The University of Ottawa Heart Institute, Ottawa, ON
14:30 - 15:15Role of cardiac MRI in the assessment of cardiotoxicity

Discussion: 15 minutes
Dr. Paaladinesh Thavendiranathan

Cardiologist, Toronto General Hospital, Toronto, ON
15:15 - 15:30Break1st Floor Atrium with OHRC
15:30 - 16:30Abstract Oral Presentations

- Abstract #1 (20 minutes)
- Abstract #2 (20 minutes)
- Abstract #3 (20 minutes)

Authors of Selected Abstracts
16:30 - 18:00Poster Session & Networking Reception with OHRC/CCONRideau Canal Atrium with OHRC
19:00 - 22:00Optional Conference Dinner

Optional Conference Dinner - RSVP Required
Location TBD
Friday, May 9, 2014
7:30 – 15:30
Time TopicLocation/Speaker
7:30 - 8:00BreakfastRideau Canal South Atrium
8:00 - 9:00Keynote Presentation:
Risk of ischemic heart disease in women after radiotherapy for breast cancer

Discussion: 15 minutes
Dr. Sarah Darby

Professor of Medicine Statistics, Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, England
9:00 - 9:45Opportunities and challenges in cardio-oncology clinical research

Discussion: 15 minutes
Dr. Edith Pituskin & Team

Assistant Clinical Professor, Radiation Oncology, University of Alberta, Cross Cancer Institute,
Edmonton, AB
9:45 - 10:30International CardiOncology Society: 2014 Update

Discussion: 15 minutes
Dr. Daniel Lenihan

Professor of Medicine; Director, Clinical Research Program, Vanderbilt Heart and Vascular Institute, Nashville, TN
10:30 - 10:45BreakRideau Canal South Atrium
10:45 - 12:00Case Studies

Group Discussion
Moderators: TBD
12:00 - 13:00LunchRideau Canal South Atrium
13:00 - 14:15Consensus Practice Guidelines

Group Discussion
Moderators: TBD
14:15 - 14:45National Cardiac Oncology Survey Results

Discussion: 10 minutes
Dr. Jeffrey Sulpher

Cardiac Oncology Fellow, The University of Ottawa & The Ottawa Hospital Cancer Centre, Ottawa, ON
14:45 - 15:15Developing a Cardiac Oncology Fellowship Program

Discussion: 10 minutes
Dr. Gillian Murtagh

Cardiac Oncology Fellow, University of Chicago,
Chicago, IL
15:15 - 15:30Closing CommentsCo-Chairs: Dr. Susan Dent & Dr. Christine Brezden-Masley